Nebzmart IL Smartules
By Nebzmart IL
Rx
5 Respules in a Packet

Composition
Levosalbutamol(1.25mg) + Ipratropium(500mcg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
September, 2026

liver
Limited information is available regarding the use of Nebzmart IL Smartules in patients with liver impairment. It is essential to consult your doctor if you have any concerns about your liver health. Your doctor will assess the potential risks and benefits before prescribing this medication. No specific interactions with the liver have been established at this time. If you have liver issues, seeking advice from your healthcare provider is crucial to ensure safe use of Nebzmart IL Smartules.

kidney
Limited info on Nebzmart IL Smartules in kidney-impaired patients. Consult doctor regarding concerns. Benefits vs. risks considered before prescribing.

alcohol
Avoid alcohol while taking Nebzmart IL Smartules due to increased drowsiness risk. Combining alcohol with this medication may lead to unwanted side effects or increased alcohol sensitivity.

driving
Duosules-Neo 500/1.25 Respules may lead to blurred vision or dizziness. If these effects occur, refrain from driving.

pregnancy
Nebzmart IL Smartules may be unsafe for use during pregnancy. Animal studies show potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before use. Limited human studies are available on its safety during pregnancy.

breastfeeding
Nebzmart IL Smartules may be safe for breastfeeding, based on limited data. It is advisable to consult a doctor for guidance on its use during breastfeeding. Further research on Duosules-Neo 500/1.25 Respules and breastfeeding is recommended.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹76
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024